Coherus BioSciences
CHRS
$1.97
Share price
-1.50%
Change (1 day)
-75.89%
Change (1 year)
Categories
Earnings for Coherus BioSciences (CHRS)
Earnings in 2023 (TTM): -$0.2 B
According to Coherus BioSciences 's latest financial reports the company's current earnings (TTM) are -$0.2 B. In 2022 the company made an earning of -$0.26 B an increase over its 2021 earnings that were of -$0.27 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Coherus BioSciences from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.2 B | -23.74% |
| 2022 | -$0.26 B | -1.84% |
| 2021 | -$0.27 B | -268.38% |
| 2020 | $0.15 B | 42.13% |
| 2019 | $0.11 B | -155.26% |
| 2018 | -$0.2 B | -12.68% |
| 2017 | -$0.23 B | 90.92% |
| 2016 | -$0.12 B | -46.49% |
| 2015 | -$0.23 B | 168.87% |
| 2014 | -$83.28 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $7.85 B | -4,072.59% | 🇺🇸 USA |
 Repligen
RGEN | $66.08 M | -133.42% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.27 B | 33.43% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | -$0.63 B | 217.06% | 🇺🇸 USA |